Assistant Professor, Medicine, University of Maryland School of Medicine
Gastroenterology
Dr. Ayse L. Mindikoglu, MD
|
|
Give Review
Ayse L. Mindikoglu is an expert in the field of Gastroenterology. She over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Mentored Patient-Oriented Research Career Development Award (NIH K23)" and "Recipient of 2004 American Association for the Study of Liver Diseases (AASLD) Advanced Hepatology Fellowship Award". Dr. Ayse L. Mindikoglu is also a published physician. She has 37 publication published. The most recent publication is: Pharmacokinetics and Tolerability of Intravenous Sildenafil in Two Subjects with Child-Turcotte-Pugh Class C Cirrhosis and Renal Dysfunction. She is registered with Medicare.
Publications
- Pharmacokinetics and Tolerability of Intravenous Sildenafil in Two Subjects with Child-Turcotte-Pugh Class C Cirrhosis and Renal Dysfunction.
- Renal dysfunction in Cirrhosis.
- Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.
- A Pilot Study to Evaluate Renal Hemodynamics in Cirrhosis by Simultaneous Glomerular Filtration Rate, Renal Plasma Flow, Renal Resistive Indices and Biomarkers Measure...
- Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in Cirrhosis.
- Impact of estimated liver volume and liver weight on gender disparity in liver transplantation.
- End-stage renal Disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infection.
- Valproic Acid-associated acute liver failure in children: case report and analysis of liver transplantation outcomes in the United States.
- Gender disparity in liver transplant waiting-list mortality: the importance of kidney function.
- Outcomes of liver transplantation in patients with Cirrhosis due to nonalcoholic steatohepatitis versus patients with Cirrhosis due to alcoholic liver disease.
- Radiofrequency ablation in patients with hepatocellular carcinoma.
- Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database.
- Hepatitis C in the elderly: epidemiology, natural history, and treatment.
- Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database.
- Imatinib mesylate (gleevec) hepatotoxicity.
- Hepatitis B virus reactivation after cytotoxic chemotherapy: the Disease and its prevention.
- HELLP Syndrome complicated bile duct injury and subsequent left hepatic lobe atrophy.
- Multiple normal deliveries in a woman with severe portal hypertension due to congenital hepatic fibrosis: the importance of preserved hepatocellular function.
- Epithelioid hemangioendothelioma of the liver.
- Focal nodular hyperplasia in identical twins.
- Platelet sparing effect of COX II inhibition used with pegylated interferon alfa-2a for the treatment of chronic Hepatitis C: a short term pilot study.
- Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with Cirrhosis and coagulopathy.
- Acute intracranial hemorrhage in a cirrhotic controlled with recombinant factor VIIa.
- Pericardiocentesis and pancreatic aspiration needle biopsy in coagulopathic and thrombocytopenic cirrhotic patient.
- The impact of nonalcoholic fatty liver Disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.
- Postoperative infections in cirrhotic patients.
- Simultaneous liver-kidney versus liver transplantation alone in patients with end-stage liver Disease and kidney dysfunction not on dialysis.
- Coagulation and fibrinolysis in individuals with advanced liver Disease.
- Cardiovascular problems in cirrhotic patients.
- Post-transplant IVC occlusion and thrombosis treated with tPA, heparin, and sharp recanalization.
- Recombinant human factor VIIa-induced alterations in tissue factor and thrombomodulin in patients with advanced liver Cirrhosis.
- Prochlorperazine-induced cholestasis in a patient with alpha-1 antitrypsin deficiency.
- Splenic embolization in a Jehovah''s Witness: role of recombinant human factor VIIa.
- Modulation of endothelial cell inflammatory integrins and stress markers with rh-factor VIIa in patients with advanced chronic Hepatitis C.
- Current concepts in the diagnosis and classification of renal dysfunction in Cirrhosis.
- Outcomes of Living Versus Deceased Donor Liver Transplantation for Acute Liver Failure in the United States.
Schools
Istanbul University Istanbul Medical Faulty
Bronx Lebanon Hospital Center
Loyola University Mc
University Miami Leonard M Miller School Med
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
Conditions Treated
- Abdominal Pain
- Anemia
- Benign Neoplasm of the Digestive System
- Cholecystitis and Gallstones
- View All
Doctors Specialties
- Gastroenterology
- Transplant Hepatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Mentored Patient-Oriented Research Career Development Award (NIH K23)
- Recipient of 2004 American Association for the Study of Liver Diseases (AASLD) Advanced Hepatology Fellowship Award
Education
-
Loyola University -
Bronx-Lebanon Hospital Center -
Istanbul University Faculty of Medicine
Hospital
-
University of Maryland Medical Center
Drug Facts
| NPI NUMBER | 1073576138 | |
| NPPES Provider LastName | MINDIKOGLU | |
| NPPES Provider FirstName | AYSE | |
| NPPES Provider ZIPCode | 212011544 | |
| NPPES Provider State | MD | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 166.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1073576138 |
| Last Name Of The Provider | MINDIKOGLU |
| First Name Of The Provider | AYSE |
| View All |
Similar Doctors
|
Dr. Elliot Schwarzenberger, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Edward J. Wolf, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allen T. Banegura, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicholas J. Belitsos, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Steven H. Epstein, MD |
|
|
Dr. Mouen A. Khashab, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Stuart K. Amateau, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth Margolis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Saleh A. Alqahtani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brindusa Truta, MD |
|
|
Dr. Mark P. Diamond, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wondwosen W. Abdi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Niraj D. Jani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Winnie Szeto, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sumita Verma, MD |